U.S. flag

An official website of the United States government

GTR Home > Tests > Genetic Study of Hereditary Thrombophilia (11 genes, 15 variants)


Sample Negative Report


Not provided

Sample Positive Report


Sample Positive Report

Variants Of Unknown Significance (VUS) Policy And Interpretation

What is the protocol for interpreting a variation as a VUS? Help
Not applicable
What is the laboratory's policy on reporting novel variations? Help
Not applicable
Are family members with defined clinical status recruited to assess significance of VUS without charge?Help
Not provided, Not applicable
Will the lab re-contact the ordering physician if variant interpretation changes? Help
Yes, The tests are constantly being updated in terms of content and genetic interest. Therefore, the doctor will be contacted if there are significant changes in the rules generated by the results obtained for the genes studied.


Is research allowed on the sample after clinical testing is complete?Help
Not applicable

Practice guidelines

  • NICE, 2023
    UK NICE Guideline NG158, Venous thromboembolic diseases: diagnosis, management and thrombophilia testing, 2023

Consumer resources

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.